By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IMPAX Laboratories 

30831 Huntwood Avenue

Hayward  California  94544  U.S.A.
Phone: 510-476-2000 Fax: 510-471-3200



Drug Delivery

Company News
IMPAX Labs (IPXL) Reports First Quarter 2016 Financial Results 5/10/2016 8:32:49 AM
IMPAX Labs (IPXL) To Present At The Bank of America (BAC) Merrill Lynch 2016 Health Care Conference 5/4/2016 8:52:11 AM
IMPAX Labs (IPXL) To Report First Quarter 2016 Results On May 10, 2016 4/19/2016 7:27:54 AM
IMPAX Labs (IPXL) Announces The Retirement Of Nigel Ten Fleming, Ph.D. And Michael Markbreiter From Its Board Of Directors 4/15/2016 6:23:22 AM
IMPAX Labs (IPXL) Announces Availability of EMVERM (mebendazole) Chewable Tablets, 100 mg 4/13/2016 6:09:14 AM
IMPAX Labs (IPXL) To Present At The Barclays Global Healthcare Conference 3/11/2016 7:38:02 AM
IMPAX Labs (IPXL) To Present At The 37th Annual Raymond James Institutional Investors Conference 3/1/2016 9:47:46 AM
IMPAX Labs (IPXL) Reports Fourth Quarter And Full Year 2015 Financial Results 2/22/2016 11:31:48 AM
IMPAX Labs (IPXL) Receives FDA Approval For Generic Version Of Adderall XR (Mixed Salts Of A Single-Entity amphetamine product) Capsules, CII 2/17/2016 5:58:26 AM
IMPAX Labs (IPXL) Receives Tentative FDA Approval For Generic Version Of Vytorin (ezetimibe And simvastatin) Tablets, 10 Mg/10 Mg, 10 Mg/20 Mg, 10 Mg/40 Mg And 10 Mg/80 Mg 2/2/2016 6:24:16 AM